Found 4374 articles for: ""
Colloid Milium: A Review and Update
March 2007 | Volume 6 | Issue 3 | Original Article | 293 | Copyright © March 2007
Colloid milium (CM) is a rare cutaneous deposition disease with at least 3 distinct subtypes. The exact histogenesis of the condition is still unresolved and awaits definitive elucidation. Electron m...
Read MoreOptimization of Narrow-Band UVB with a 5% Oleic Acid Cream in the Treatment of Psoriasis
March 2007 | Volume 6 | Issue 3 | Original Article | 290 | Copyright © March 2007
Oleic acid is a monounsaturated fatty acid with a known action of penetration enhancer which has been used for various purposes, such as a tanning increaser. Narrow-band ultraviolet B (UVB) is a also...
Read MoreXeroderma Pigmentosum: Beyond Skin Cancer
March 2007 | Volume 6 | Issue 3 | Original Article | 281 | Copyright © March 2007
Xeroderma pigmentosum (XP) is a rare, autosomal-recessive inherited disease that is found worldwide at a frequency of approximately 1:250,000. XP is caused by a deficiency in either nucleotide excisi...
Read MoreIdentification of Novel Hsp65 RFLPs for Mycobacterium Leprae
March 2007 | Volume 6 | Issue 3 | Original Article | 268 | Copyright © March 2007
Leprosy or Hansen’s disease is a chronic infectious disease caused by an acid-fast bacillus, Mycobacterium leprae (M. leprae). The bacilli proliferate in macrophages infiltrating the skin and gain ...
Read MoreOutcomes Associated with the Use of Biologic Agents in Moderate to Severe Psoriasis
March 2007 | Volume 6 | Issue 3 | Original Article | 259 | Copyright © March 2007
An estimated 2.1% of Americans have psoriasis and approximately 30% of them have moderate to severe psoriasis. Although the disease is not associated with mortality, it has a significant impact on he...
Read MoreClinical Trial Review
February 2007 | Volume 6 | Issue 2 | Features | 236 | Copyright © February 2007
Pipeline Previews
February 2007 | Volume 6 | Issue 2 | Features | 233 | Copyright © February 2007
Washington Whispers
February 2007 | Volume 6 | Issue 2 | Features | 227 | Copyright © February 2007
Pearls: Eye Protection During Cryosurgery
February 2007 | Volume 6 | Issue 2 | Features | 226 | Copyright © February 2007
Dermoscopy as a Tool for Rapid Diagnosis of Monilethrix
February 2007 | Volume 6 | Issue 2 | Case Reports | 222 | Copyright © February 2007
Monilethrix is a rare cause of hair loss. We present a case of a 44-year-old female, in whom dermoscopy enabled a rapid diagnosis of monilethrix. Dermoscopy images in this patient showed hair shafts ...
Read MorePotential Foreign Body Emboli Associated with Botulinum Toxin A Injections
February 2007 | Volume 6 | Issue 2 | Case Reports | 220 | Copyright © February 2007
Although the injection of Botox Cosmetic for the treatment of dynamic rhytids is safe and effective, there is a potential risk for foreign body embolization. This case report documents the presence o...
Read MoreBexarotene and Interferon-α Combination Therapy in a Patient Affected by Relapsing Anaplastic Large Cell Lymphoma with Cutaneous Involvement
February 2007 | Volume 6 | Issue 2 | Case Reports | 216 | Copyright © February 2007
A 74-year-old man presented with relapsing systemic anaplastic large cell lymphoma (ALCL) with cutaneous involvement who had a third recurrence of cutaneous lesions associated with inguinal lymphonod...
Read MoreSkin Tightening by a New Unipolar and Bipolar Radiofrequency Device
February 2007 | Volume 6 | Issue 2 | Case Reports | 212 | Copyright © February 2007
Monopolar radiofrequency (RF) devices are well established treatment modalities for tightening facial skin. A 60-yearold woman presented with a desire to tighten the lax skin and improve the appearan...
Read MoreOsteomyelitis Occurring during Infliximab Treatment of Severe Psoriasis
February 2007 | Volume 6 | Issue 2 | Case Reports | 297 | Copyright © February 2007
Tumor necrosis factor alpha (TNF-?) inhibitors, such as infliximab, decrease the body’s inflammatory response and thus the body’s reaction to infection. Given the immune-mediated processes in pso...
Read MorePalliative Treatment of Fingernail Lichen Planus
February 2007 | Volume 6 | Issue 2 | Case Reports | 202 | Copyright © February 2007
Lichen planus of the nails is a destructive inflammatory onychodystrophy that is often difficult to treat. We report a case of treatment with combined topical therapy of tazarotene gel and clobetasol...
Read MoreEfficacy of Novel Skin Cream Containing Mixture of Human Growth Factors and Cytokines for Skin Rejuvenation
February 2007 | Volume 6 | Issue 2 | Original Article | 197 | Copyright © February 2007
The crucial role of growth factors and cytokines in cutaneous wound healing is well described, but there has been little investigation into their use for skin rejuvenation. A novel skin cream contain...
Read MorePharmacokinetics of Tacrolimus Following Topical Application of Tacrolimus Ointment in Adult and Pediatric Patients with Moderate to Severe Atopic Dermatitis
February 2007 | Volume 6 | Issue 2 | Original Article | 185 | Copyright © February 2007
Objective: To characterize the pharmacokinetics of tacrolimus after topical application in adult and pediatric patients with moderate to severe atopic dermatitis from all clinical trials in which tac...
Read MoreSafety and Efficacy of Desonide Hydrogel 0.05% in Pediatric Subjects with Atopic Dermatitis
February 2007 | Volume 6 | Issue 2 | Original Article | 175 | Copyright © February 2007
Low to mid potency corticosteroids remain a cornerstone of therapy for atopic dermatitis (AD). Since AD is most prevalent in the younger pediatric population and is chronic in nature, safety is of pa...
Read MoreColloidal Oatmeal: History, Chemistry and Clinical Properties
February 2007 | Volume 6 | Issue 2 | Original Article | 1671 | Copyright © February 2007
Oatmeal has been used for centuries as a soothing agent to relieve itch and irritation associated with various xerotic dermatoses. In 1945, a ready to use colloidal oatmeal, produced by finely grindin...
Read MoreCost-Effectiveness of a Fixed Combination of Hydroquinone/Tretinoin/Fluocinolone Cream Compared with Hydroquinone Alone in the Treatment of Melasma
February 2007 | Volume 6 | Issue 2 | Original Article | 153 | Copyright © February 2007
Background: A once-daily fixed combination of hydroquinone, tretinoin, and fluocinolone acetonide (Tri-luma) is a newly available treatment for melasma.
Objective: To assess cost-effectiven...
Read More